Literature DB >> 29715091

Podoplanin Expression as a Prognostic Factor in Gastric Cancer.

Suguru Maruyama1, Shinji Furuya1, Kensuke Shiraishi1, Hiroki Shimizu1,2, Hidenori Akaike1, Naohiro Hosomura1, Yoshihiko Kawaguchi1, Hidetake Amemiya1, Hiromichi Kawaida1, Makoto Sudo1, Shingo Inoue1, Hiroshi Kono1, Daisuke Ichikawa3.   

Abstract

BACKGROUND/AIM: Several recent studies have suggested that podoplanin (PDPN) expression correlates with malignant potential in various types of cancers. We investigated the expression pattern of PDPN and its clinical significance in gastric cancer.
MATERIALS AND METHODS: We assessed the immunohistochemical expression of PDPN in 91 gastric cancer tissues of patients who underwent curative surgery and evaluated the relationship between the expression levels and clinicopathological factors.
RESULTS: The tumor cells themselves revealed no expression of PDPN. However, PDPN was expressed in spindle-shaped stromal cells surrounding tumors in certain cases. PDPN-positive stromal cells significantly correlated with a larger tumor, advanced T- and N-stages, and lymphatic and vascular invasion. Multivariate analysis indicated that PDPN expression in spindle-shaped stromal cells (p=0.030) as well as N-stage (p=0.023) are independent prognostic factors.
CONCLUSION: Our findings demonstrated the PDPN expression in spindle-shaped stromal cells of patients with gastric cancers has a prognostic significance. Intensive chemotherapy and close follow-up should be recommended for these patients. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  CAFs; Podoplanin; gastric cancer

Mesh:

Substances:

Year:  2018        PMID: 29715091     DOI: 10.21873/anticanres.12513

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1-Mediated Secretion of Extracellular Vesicles.

Authors:  Nil Grunberg; Meirav Pevsner-Fischer; Tal Goshen-Lago; Judith Diment; Yaniv Stein; Hagar Lavon; Shimrit Mayer; Oshrat Levi-Galibov; Gil Friedman; Yifat Ofir-Birin; Li-Jyun Syu; Cristina Migliore; Eyal Shimoni; Salomon M Stemmer; Baruch Brenner; Andrzej A Dlugosz; David Lyden; Neta Regev-Rudzki; Irit Ben-Aharon; Ruth Scherz-Shouval
Journal:  Cancer Res       Date:  2021-02-05       Impact factor: 12.701

2.  Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 - negative subtype.

Authors:  Yuko Tanaka; Takashi Ohno; Taichi Kadonaga; Yoshiteru Kidokoro; Makoto Wakahara; Kanae Nosaka; Tomohiko Sakabe; Yoshimasa Suzuki; Hiroshige Nakamura; Yoshihisa Umekita
Journal:  Breast Cancer       Date:  2021-01-22       Impact factor: 4.239

3.  PDPN is a prognostic biomarker and correlated with immune infiltrating in gastric cancer.

Authors:  Liya Hu; Peng Zhang; Wei Sun; Lei Zhou; Qian Chu; Yuan Chen
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

4.  Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer.

Authors:  Yongchen Ma; Jing Zhu; Shanwen Chen; Tengyu Li; Ju Ma; Shihao Guo; Jianwen Hu; Taohua Yue; Junling Zhang; Pengyuan Wang; Xin Wang; Guowei Chen; Yucun Liu
Journal:  Cancer Cell Int       Date:  2018-07-20       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.